1 month Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Rating of “Moderate Buy” from AnalystsMarketBeat
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have earned an average rating of “Moderate Buy” from the ten analysts that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a ho…
X